GSTP1 Ile105Val polymorphism among North Indian lung cancer patients treated using monotherapy and poly-pharmacy.

Harleen Kaur WaliaNavneet SinghSiddharth Sharma

Published in: Human & experimental toxicology (2021)

Our results suggest that GSTP1 Ile105Val polymorphism could be a predictive biomarker for hematological toxicity, like leukopenia and anemia, but not thrombocytopenia or neutropenia.

Keyphrases

chronic kidney disease
oxidative stress
combination therapy
open label
randomized controlled trial
tertiary care
chemotherapy induced
study protocol